OTC · GRTX
Galera Therapeutics, Inc.
Healthcare · Biotechnology
$17.15
Up+$1.53 (+9.80%)
Updated Sep 16, 2026, 8:38 AM
SID Score
5.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.81M
- P/E ratio
- -0.18
- Dividend yield
- 0.00%
- 52-week range
- $0.02 – $0.06
- Volume
- 65.01K
- Avg. volume
- 125.56K
Price performance
GRTX price history
1M range · 0 trading sessions · Daily adjusted prices
GRTX does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest GRTX news
The latest Smart Investors Daily articles mentioning GRTX.
Stock researchCompany · Overview
GRTX research
Overview
Company profile and research snapshot.
Company profile
GALERA THERAPEUTICS INC
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 29, 2023 | Citigroup | Neutral | — |
| Aug 16, 2023 | HC Wainwright & Co. | Neutral | — |
| Aug 10, 2023 | Piper Sandler | Neutral | — |
| Jul 17, 2023 | HC Wainwright & Co. | Buy | — |
| Mar 22, 2023 | HC Wainwright & Co. | Buy | — |
News briefing
Data unavailable
Market data is busy. Please try again shortly.
AI research layers
Interpretive context generated from the platform’s current data sources.
Data unavailable
Market data is busy. Please try again shortly.

